Fio Corp. repurposes FIONET to fight COVID-19
Its data-and-device platform, FIONET to expand frontline testing, triage, tracking
Toronto-based medical equipment manufacturer Fio Corp. is introducing Fionet, a technology to expand the capability of frontline healthcare workers to combat COVID-19.
Its platform, Fionet, treated 1 million patients in a dozen countries for managing biothreats such as HIV, malaria, dengue, and Ebola.
The company said in a statement that Fionet can help defeat the COVID-19 pandemic beyond the few overburdened medical centres and labs to thousands of frontline health posts, such as pharmacies, clinics, airports, and workplaces.
According to the company, Fionet reads diagnostic tests in seconds. Fionet operates with 3rd-party databases and electronic-health-record (EHR) systems.
“Fionet enables everyday healthcare workers deliver expert-level diagnostic testing and triage at frontline health posts. In real time, supervisors can remotely see and guide frontline healthcare activity,” said Michael Greenberg, CEO of Fio Corporation in a prepared statement.
“Public health officials can manage responses and resources to new levels of precision and promptness. And in the process, it digitizes all frontline activity.”